From left: Myosana CEO Matthew Lumley, with co-founders Stanley Froehner and Nick Whitehead. (Myosana and UW Photos) The news: Myosana Therapeutics, a Seattle startup developing gene therapy ...

IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. Fritz Frohse (1871-1916), a physician ...

Biogen Inc. (($BIIB)) announced an update on their ongoing clinical study. Biogen Inc., in collaboration with Alcyone Therapeutics, is conducting ...